AIM:To construct and evaluate the functionality of a choanoid-fluidized bed bioreactor(CFBB)based on microencapsulated immortalized human hepatocytes.METHODS:Encapsulated hepatocytes were placed in the constructed CFB...AIM:To construct and evaluate the functionality of a choanoid-fluidized bed bioreactor(CFBB)based on microencapsulated immortalized human hepatocytes.METHODS:Encapsulated hepatocytes were placed in the constructed CFBB and circulated through Dulbecco’s Modified Eagle’s Medium(DMEM)for 12 h,and then through exchanged plasma for 6 h,and compared with encapsulated cells cultivated under static conditions in a spinner flask.Levels of alanine aminotransferase(ALT)and albumin were used to evaluate the CFBB during media circulation,whereas levels of ALT,total bilirubin(TBil),and albumin were used to evaluate it during plasma circulation.Mass transfer and hepatocyte injury were evaluated by comparing the results from the two experimental conditions.In addition,the viability and microstructure of encapsulated cells were observed in the different environments.RESULTS:The bioartificial liver model based on a CFBB was verified by in vitro experiments.The viability of encapsulated cells accounting for 84.6%±3.7%in CFBB plasma perfusion was higher than the 74.8%±3.1%in the static culture group(P<0.05)after 6 h.ALT release from cells was 29±3.5 U/L vs 40.6±3.2U/L at 12 h(P<0.01)in the CFBB medium circulation and static medium culture groups,respectively.Albumin secretion from cells was 234.2±27.8μg/1×107cells vs 167.8±29.3μg/1×107 cells at 6 h(P<0.01),274.4±34.6μg/1×107 cells vs 208.4±49.3μg/1×107 cells(P<0.05)at 12 h,in the two medium circulation/culture groups,respectively.Furthermore,ALT and TBil levels were 172.3±24.1 U/L vs 236.3±21.5 U/L(P<0.05),240.1±23.9μmol/L vs 241.9±31.4μmol/L(P>0.05)at 6 h in the CFBB plasma perfusion and static plasma culture groups,respectively.There was no significant difference in albumin concentration between the two experimental plasma groups at any time point.The microstructure of the encapsulated hepatocytes remained healthier in the CFBB group compared with the static culture group after 6 h of plasma perfusion.CONCLUSION:The CFBB can function as a bioartificial liver based on a bioreactor.The efficacy of this novel bioreactor is promising for the study of liver failure.展开更多
基金Supported by The Grants from the National Scientific and Technological Major Project of China,No.2011ZX10004-901,No.2013ZX10004904the National Science and Technology Major Project,No.2012ZX10002006
文摘AIM:To construct and evaluate the functionality of a choanoid-fluidized bed bioreactor(CFBB)based on microencapsulated immortalized human hepatocytes.METHODS:Encapsulated hepatocytes were placed in the constructed CFBB and circulated through Dulbecco’s Modified Eagle’s Medium(DMEM)for 12 h,and then through exchanged plasma for 6 h,and compared with encapsulated cells cultivated under static conditions in a spinner flask.Levels of alanine aminotransferase(ALT)and albumin were used to evaluate the CFBB during media circulation,whereas levels of ALT,total bilirubin(TBil),and albumin were used to evaluate it during plasma circulation.Mass transfer and hepatocyte injury were evaluated by comparing the results from the two experimental conditions.In addition,the viability and microstructure of encapsulated cells were observed in the different environments.RESULTS:The bioartificial liver model based on a CFBB was verified by in vitro experiments.The viability of encapsulated cells accounting for 84.6%±3.7%in CFBB plasma perfusion was higher than the 74.8%±3.1%in the static culture group(P<0.05)after 6 h.ALT release from cells was 29±3.5 U/L vs 40.6±3.2U/L at 12 h(P<0.01)in the CFBB medium circulation and static medium culture groups,respectively.Albumin secretion from cells was 234.2±27.8μg/1×107cells vs 167.8±29.3μg/1×107 cells at 6 h(P<0.01),274.4±34.6μg/1×107 cells vs 208.4±49.3μg/1×107 cells(P<0.05)at 12 h,in the two medium circulation/culture groups,respectively.Furthermore,ALT and TBil levels were 172.3±24.1 U/L vs 236.3±21.5 U/L(P<0.05),240.1±23.9μmol/L vs 241.9±31.4μmol/L(P>0.05)at 6 h in the CFBB plasma perfusion and static plasma culture groups,respectively.There was no significant difference in albumin concentration between the two experimental plasma groups at any time point.The microstructure of the encapsulated hepatocytes remained healthier in the CFBB group compared with the static culture group after 6 h of plasma perfusion.CONCLUSION:The CFBB can function as a bioartificial liver based on a bioreactor.The efficacy of this novel bioreactor is promising for the study of liver failure.
基金The authors gratefully acknowledge the supports from China Postdoctoral Science Foundation （Grant No. 2014M550327）, the opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, and the National Natural Science Foundation of China （Grant No. 11372275）. The authors are also grateful to Chengbo Yu and Liang Yu for their introduction of the choanoid fluidized bed bioreactor and helpful discussions.
